Search company, investor...


Acquired | Acquired

About ReproMed

ReproMed provides fertility treatment services. On January 14th, 2021, ReproMed was acquired by The Fertility Partners, terms of the transaction were not disclosed.

Headquarters Location

56 Aberfoyle Cres. Suite 300

Toronto, Ontario, M8X 2W4,




Latest ReproMed News

Insights on the Donor Egg IVF Services Global Market to 2027 - Featuring Procrea Fertility, Raffles Medical Group and Repromed Among Others -

Jul 11, 2022

The Global Donor Egg IVF Services Market size was estimated at USD 1,884.34 million in 2021, USD 2,067.46 million in 2022, and is projected to grow at a Compound Annual Growth Rate (CAGR) of 9.89% to reach USD 3,319.14 million by 2027. Competitive Strategic Window: The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period. FPNV Positioning Matrix: The FPNV Positioning Matrix evaluates and categorizes the vendors in the Donor Egg IVF Services Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape. Market Share Analysis: The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits. The report provides insights on the following pointers: 1. Market Penetration: Provides comprehensive information on the market offered by the key players 2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments The report answers questions such as: 1. What is the market size and forecast of the Global Donor Egg IVF Services Market? 2. What are the inhibiting factors and impact of COVID-19 shaping the Global Donor Egg IVF Services Market during the forecast period? 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Donor Egg IVF Services Market? 4. What is the competitive strategic window for opportunities in the Global Donor Egg IVF Services Market? 5. What are the technology trends and regulatory frameworks in the Global Donor Egg IVF Services Market? 6. What is the market share of the leading vendors in the Global Donor Egg IVF Services Market? 7. What modes and strategic moves are considered suitable for entering the Global Donor Egg IVF Services Market? Market Dynamics Increasing infertility patients due to unhealthy lifestyle Increase in gamete donations Religion or social concern Increasing fertility tourism

ReproMed Frequently Asked Questions (FAQ)

  • Where is ReproMed's headquarters?

    ReproMed's headquarters is located at 56 Aberfoyle Cres., Toronto.

  • What is ReproMed's latest funding round?

    ReproMed's latest funding round is Acquired.

  • Who are the investors of ReproMed?

    Investors of ReproMed include The Fertility Partners.



CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.